HC Wainwright & Co. Downgrades Caribou Biosciences to Neutral

Benzinga Newsdesk www.benzinga.com Negative 92.2%

Neg 92.2% Neu 0% Pos 0%

HC Wainwright & Co. analyst Robert Burns downgrades Caribou Biosciences (NASDAQ:CRBU) from Buy to Neutral.

Comments

No comments yet. Be the first!